IL6 and hepatocellular carcinoma: IL-6, as an inflammatory-related tumor cytokine, activates a series of factors downstream by activating the IL-6/STAT3 signaling pathway, leading to the occurrence of malignant behaviors, such as HCC cell proliferation, drug resistance, invasion and metastasis (18, 19).